Codexis Partners with siRNA Innovator to Advance Enzymatic Oligonucleotide Manufacturing

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced an agreement with ...

September 30, 2026 | Wednesday | News
Tandem Diabetes Care Expands Tandem Mobi Automated Insulin Delivery to 12 Global Markets

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, announced that Tandem Mobi, the world’s smalle...

September 29, 2026 | Tuesday | News
QIAGEN Expands US QIAstat-Dx Bloodstream Infection Testing with New FDA-Cleared Panel

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced that U.S. laboratories now have access to the complete QIAstat-Dx bloodstream infection p...

September 29, 2026 | Tuesday | News
Sun Nuclear Validates AdaptCHECK for Siemens Healthineers’ Accela Adaptive Radiotherapy System

Sun Nuclear, a Mirion Medical company, announced that its AdaptCHECK™ software has been validated in collaboration with Siemens Healthineers technica...

September 29, 2026 | Tuesday | News
Grünenthal and DKSH Expand Asia-Pacific Partnership to Broaden Access to Pain Medicines

Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthcare business partner and leading pr...

September 29, 2026 | Tuesday | News
Accuray and Samsung NeuroLogica Advance Volumetric Imaging for CyberKnife Platform

Accuray Incorporated (NASDAQ: ARAY) announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogi...

September 29, 2026 | Tuesday | News
Astellas Doses First Patient in Phase 3 Trial of Setidegrasib for KRAS G12D-Mutated Lung Cancer

Astellas Pharma Inc.announced that the first patient has been dosed in a Phase 3 study evaluating setidegrasib, a novel, investigational KRAS G12D-t...

September 25, 2026 | Friday | News
ACROBiosystems Expands French Presence With New Hub at Kadans Science Partner’s The HIVE

Kadans Science Partner is pleased to welcome ACROBiosystems to The HIVE Innovation Center, its laboratory and office building dedicated to the life scien...

September 25, 2026 | Friday | News
InnoCare Pharma and Eli Lilly Partner to Develop New Medicines Across Five Targets

InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced that the Company has entered ...

September 25, 2026 | Friday | News
Lōkahi Therapeutics and University of Alabama Extend Biopharma Asset Evaluation Collaboration

Lōkahi Therapeutics, a subsidiary of Glucotrack, Inc., announced that The University of Alabama’s Culverhouse College of Business will continue it...

September 22, 2026 | Tuesday | News
Cue Biopharma Reports Positive Phase 2 Results for CUE-221 in Chronic Spontaneous Urticaria

  Cue Biopharma, a clinical-stage biopharmaceutical company targeting transformative therapies for immune-mediated diseases, announced positive topli...

September 22, 2026 | Tuesday | News
Silo Pharma Receives USPTO Notice of Allowance for SPC-15 PTSD Therapeutic

Silo Pharma (“Silo” or “the Company”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug del...

September 21, 2026 | Monday | News
EB Development Plans Public Withdrawal Offer for Eurobio Scientific at €25.30 Per Share

EB Development, a company owned directly or indirectly by funds managed by IK Partners and former reference shareholders of Eurobio Scientific (FR0013240...

September 18, 2026 | Friday | News
Flow Neuroscience Launches FDA-Approved FL-100 At-Home tDCS Treatment in the US

Flow Neuroscience announced that FL-100 is now available by prescription across the United States, introducing the first FDA-approved at-home transc...

September 18, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close